tiprankstipranks
Advertisement
Advertisement
GoodRx Chief Accounting Officer Resigns for New Opportunity
PremiumCompany AnnouncementsGoodRx Chief Accounting Officer Resigns for New Opportunity
1M ago
GoodRx announces resignation of Chief Accounting Officer Romin Nabiey
Premium
The Fly
GoodRx announces resignation of Chief Accounting Officer Romin Nabiey
1M ago
Novo Nordisk (NVO) Wins FDA Nod for High-Dose Wegovy amid Surging Obesity Drug Demand
Premium
Market News
Novo Nordisk (NVO) Wins FDA Nod for High-Dose Wegovy amid Surging Obesity Drug Demand
2M ago
GoodRx price target lowered to $3.50 from $4.50 at Citi
PremiumThe FlyGoodRx price target lowered to $3.50 from $4.50 at Citi
2M ago
GoodRx price target lowered to $2.50 from $4 at Goldman Sachs
Premium
The Fly
GoodRx price target lowered to $2.50 from $4 at Goldman Sachs
2M ago
GoodRx Earnings Call Marks Transitional Reset Year
Premium
Company Announcements
GoodRx Earnings Call Marks Transitional Reset Year
2M ago
GoodRx price target lowered to $2 from $4 at UBS
PremiumThe FlyGoodRx price target lowered to $2 from $4 at UBS
2M ago
Balancing Near-Term Headwinds and Long-Term Growth: Justifying a Buy/High-Risk Rating on Pharma Direct-Led Upside
Premium
Ratings
Balancing Near-Term Headwinds and Long-Term Growth: Justifying a Buy/High-Risk Rating on Pharma Direct-Led Upside
2M ago
GoodRx price target lowered to $3 from $4 at Mizuho
Premium
The Fly
GoodRx price target lowered to $3 from $4 at Mizuho
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100